DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
Podcast tekijän mukaan DrugPatentWatch
100 Jaksot
-  
Drug Excipient Business Development Reports now Available on Amazon
Julkaistiin: 15.2.2024 -  
Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters
Julkaistiin: 30.1.2024 -  
Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book
Julkaistiin: 22.1.2024 -  
An AI Approach to Generate Novel Pharmaceuticals using Patent Data
Julkaistiin: 16.1.2024 -  
NPR on how low Drug Prices can Cause Shortages
Julkaistiin: 9.1.2024 -  
Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals
Julkaistiin: 8.1.2024 -  
Decoding Pfizer’s Portfolio: A New Model for Precision in Pharma Investments
Julkaistiin: 11.12.2023 -  
Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases
Julkaistiin: 17.11.2023 -  
AI-Driven Strategies: Pharma’s Answer to Patent Expirations
Julkaistiin: 12.11.2023 -  
Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents
Julkaistiin: 6.11.2023 -  
Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma
Julkaistiin: 30.10.2023 -  
List of research papers citing DrugPatentWatch
Julkaistiin: 25.10.2023 -  
Influencers of Generic Drug Utilization
Julkaistiin: 16.10.2023 -  
Reviving an R&D Pipeline
Julkaistiin: 9.10.2023 -  
Factors that May Predict the Likelihood of Generic Drug Marketing Applications
Julkaistiin: 2.10.2023 -  
Measuring Patent Value Indicators
Julkaistiin: 25.9.2023 -  
Maximizing Drug Patents’ Value: Strategies for Biomedical Companies
Julkaistiin: 18.9.2023 -  
From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO
Julkaistiin: 12.9.2023 -  
Understanding Patent Term Extensions: An Overview
Julkaistiin: 12.9.2023 -  
Pharmacists Can Play Key Role in Drug Repurposing
Julkaistiin: 5.9.2023 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
 